Newsroom

DUBLIN--(BUSINESS WIRE)--The "Manufacture of Flour and Grain Mill Products in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report focuses on the manufacture of flour and grain mill products, including the milling of maize and wheat. It provides information on production and consumption, prices and inflation, consumption trends, food security, input costs, competition and regulation. The report includes information on new investments, notable players and co...

TOKYO--(BUSINESS WIRE)--LogProstyle Inc. (NYSE American: LGPS) (the “Company” or “LogProstyle”), a leading real estate renovation and resale, development, hotel and restaurant management company, today announced that it will process a refund of Japanese withholding income tax in connection with the cash dividend described below, as previously disclosed by the Company on July 7, 2025. Cash Dividend Parameters: Record Date: July 7, 2025 Payment Date: August 5, 2025 Dividend per Share: US$0.023 Ca...

HOUSTON--(BUSINESS WIRE)--Starlab Space LLC (Starlab) announces the company has received an investment from Sumitomo Mitsui Trust Bank, Limited (SuMi TRUST Bank)....

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens on Thursday, January 29, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our websit...

NEW YORK & NAPLES, Fla.--(BUSINESS WIRE)--Hilton Global Associates Inc. (“Hilton Global”) is pleased to announce the appointment of Heather Calabret-Morison as Senior Director of Business Development. Heather brings extensive experience in enhanced due diligence across private markets, working hand-in-hand with compliance professionals, legal teams, and investment professionals throughout the deal lifecycle. In her new role, Heather will focus on expanding and strengthening institutional client...

NEW YORK--(BUSINESS WIRE)--Spotify Technology S.A. (NYSE: SPOT) will post its fourth quarter 2025 results and deck to shareholders on Tuesday, February 10, 2025 before market open. The company will hold a question and answer session to discuss fourth quarter 2025 results at 8:00 am Eastern Time. Management will answer questions submitted via Slido. Questions may be submitted on the day of the call at www.slido.com using the event code #SpotifyEarningsQ425. A live webcast of the earnings call wi...

DUBLIN--(BUSINESS WIRE)--The "Manufacturing Trends in South Africa 2025" report has been added to ResearchAndMarkets.com's offering. This report on trends in the manufacturing sector in South Africa, which is concentrated in the food and beverages, metal, petrochemical and automotive industries, provides information on the size and state of the manufacturing sector including contribution to GDP, performance, employment, production, profitability, trade, tariffs and fixed investment. Investing i...

DUBLIN--(BUSINESS WIRE)--The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Semaglutide Market is expected to expand from US$ 8.17 Billion in 2024 to US$ 17.29 Billion in 2033 at a Compound Annual Growth Rate (CAGR) of 8.68% during 2025-2033 The growth is fueled by rising awareness regarding obesity control, increasing incidence of diabetes,...

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% The report will help market leaders/new...

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 Billion in 2024 and is projected to reach US$29.8 Billion by 2030, growing at a CAGR of 9.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Liraglutide and s...